Medication info
Megarojet Tablet 10/20 Milligrams

Megarojet Tablet 10/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Pink oval film-coated tablets
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201506791 · Approved 2015.09.24 · Insurance code 652105490

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL-cholesterol
  • increased apo B protein
  • elevated triglycerides
  • increased non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
View approved original text

This medication is used in conjunction with diet to lower total cholesterol, LDL-cholesterol, apo B protein, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels. It is administered particularly to individuals at high risk of atherosclerotic vascular disease due to hypercholesterolemia, and underlying causes of dyslipidemia should be checked and treated as necessary before starting drug therapy. This drug should be used alongside an appropriate diet, mainly used when there is insufficient response to dietary management or non-pharmacological measures. Monitoring and managing blood lipid levels is essential, and lipid testing should be done during hospitalization in the case of acute coronary events to determine treatment direction. This treatment helps control blood lipid levels and reduce the risk of cardiovascular diseases.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This drug lowers blood cholesterol levels by inhibiting cholesterol biosynthesis in the liver. Caution is advised as symptoms like muscle pain or weakness may occur before taking this medication. Patients at high risk of severe myopathy or rhabdomyolysis should temporarily discontinue or stop this medication. Since this drug may affect liver function, patients with liver disease or abnormally high liver enzyme levels should not use it. Additionally, patients with severely impaired kidney function or muscle disorders should also avoid this drug. Women who are pregnant or may become pregnant, as well as breastfeeding mothers, should not take this medication. Alcoholics or patients with a history of liver dysfunction should use this medication with caution and undergo regular liver function tests during treatment. If symptoms such as muscle pain, muscle cramps, or muscle weakness occur while taking this medication, one should inform a doctor immediately, and blood tests may be necessary to check for muscle damage. Furthermore, interactions may occur when used with other medications, so it is essential to inform healthcare professionals of any other medications being taken. This drug is not recommended for children as safety and efficacy have not been established, and caution is advised for the elderly due to the risk of myopathy. Caution is required when driving or operating machinery, as dizziness may occur. If skin reactions occur while taking this medication, it should be discontinued immediately, and consult with healthcare professionals. In cases of overdose, there is no specific antidote, and treatment and supportive care should be based on symptoms, while monitoring liver function and muscle enzyme levels.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, ALT elevation, edema, muscle pain, AST elevation, headache, acute pyelonephritis, dry mouth, liver enzyme elevation, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, chest pain, facial edema, unusual sensation, drug intolerance, colorectal polyp, irritable bowel syndrome, esophagitis, dizziness, lethargy, neurodegenerative disorders, orthostatic dizziness, migraine, elevated blood sugar, chest discomfort, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, fatty liver disease, liver impairment, liver toxicity, acute hepatitis, toxic hepatitis, elevated gamma-glutamyl transferase, increased blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, drooping eyelids, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, vascular edema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory decline, forgetfulness, dementia, memory disturbances, confusion, severe muscle weakness, ocular myasthenia, elevated CK, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, loss of appetite, abdominal distension, syncope, generalized pain, joint pain, thrombocytopenia, increased serum creatinine, acute renal failure, oliguria

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air or moisture from entering, ideally at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy over a long period and ensure safe use.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.